Was just an opinion. To elaborate, there's nearly a billion...

Was just an opinion. To elaborate, there's nearly a billion shares on issue, and no indication that more won’t be needed to manufacture the next iteration of buds.

I don't think they have the luxury of heaps of money to throw around manufacturing an additional product line (without additional dilution and capital raising).

A successful business should focus on doing one or two things really well and improving on that before branching out. Make sure the core product sells. People have been waiting years now for a hint of profitability and I personally don’t see any evidence of it.

Are people going to say “just wait till the next quarterly for revenue” in 2020 as well? Probably. I heard the same rhetoric when it was announced that NUH was on the Aus Gov Hearing Services Program contract and everyone was talking about making big bucks then. Now you are all going on about NHS revenue.

Wonder what it will be next!